Overview
Drug-induced dyskinesia refers to involuntary movements caused by medication use, often seen with certain antipsychotics and anticonvulsants. 2 highlights a specific manifestation in dermatological contexts, such as minocycline-induced lysosomal disorders leading to unique presentations like black thyroid discoloration.Diagnosis
Clinical presentation of involuntary movements (dystonia, chorea, etc.) 2
Detailed medication history to identify potential causative agents 2
Histological examination in specific cases (e.g., black thyroid) showing characteristic intracellular material accumulation 2Management
Discontinue or adjust the offending medication 2
Symptomatic treatment with benzodiazepines or anticholinergics as needed 2
No specific dosing mentioned; individualized based on patient response 2Special Populations
Pregnancy: Limited data; cautious medication selection and close monitoring advised 1
Pediatrics: Susceptibility to adverse reactions may vary; genetic predisposition screening recommended if available 1
Elderly: Increased risk of drug interactions and adverse effects; careful medication review essential 1
Comorbidities: Patients with existing neurological conditions may require tailored management strategies 2Key Recommendations
Conduct a thorough medication review to identify and discontinue potential causative agents for drug-induced dyskinesia (Evidence: Moderate 2)
Consider genetic testing for patients at risk of severe cutaneous adverse reactions to tailor pharmacotherapy (Evidence: Moderate 1)
Monitor patients closely, especially those with pre-existing conditions or in vulnerable populations, for early signs of dyskinesia (Evidence: Expert opinion 2)References
1 Borroni RG. Role of dermatology in pharmacogenomics: drug-induced skin injury. Pharmacogenomics 2015. link
2 Reid JD. The black thyroid associated with minocycline therapy. A local manifestation of a drug-induced lysosome/substrate disorder. American journal of clinical pathology 1983. link